» Articles » PMID: 10451708

Trisomy 21 is a Recurrent Secondary Aberration in Childhood Acute Lymphoblastic Leukemia with TEL/AML1 Gene Fusion

Overview
Date 1999 Aug 19
PMID 10451708
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

TEL/AML1 gene fusion is the most frequent genetic lesion in pediatric acute lymphoblastic leukemia (ALL). It occurs as a consequence of the cryptic chromosomal translocation t(12;21)(p13;q22). In a cohort of 50 RT-PCR-positive TEL/AML1 patients, karyotype examination by GTG banding and fluorescence in situ hybridization (FISH) allowed us to identify chromosome anomalies in addition to the already existing t(12;21). Secondary aberrations were found in 29 out of 41 patients (71%) at initial diagnosis and in all 9 patients with relapse. Structural rearrangements affected chromosome arms 2p, 2q, 5q, 9p, 12p (n = 2), 6q, 11p (n = 3), and 21q (n = 4). An extra chromosome 21 was found to be the most frequent anomaly. It was detected in 6 out of 41 patients at initial diagnosis (15%) and in 7 out of the 9 patients at relapse. No karyotype with trisomy 21 exceeded 47 chromosomes. Gain of chromosome 21 was the sole anomaly in GTG-banding analysis in 2/41 patients at initial diagnosis and in 4/9 at relapse. Notably, chromosome painting analysis performed in 11 out of the 13 patients with an extra chromosome 21 revealed duplication of the normal chromosome 21 in 8, and duplication of der(21)t(12;21) in 3 patients. Furthermore, gain of der(21)t(12;21) chromosome was confined exclusively to the relapse patients.

Citing Articles

Genetic Biomarkers and Their Clinical Implications in B-Cell Acute Lymphoblastic Leukemia in Children.

Lejman M, Chalupnik A, Chilimoniuk Z, Dobosz M Int J Mol Sci. 2022; 23(5).

PMID: 35269896 PMC: 8911213. DOI: 10.3390/ijms23052755.


Constitutive Activation of RAS/MAPK Pathway Cooperates with Trisomy 21 and Is Therapeutically Exploitable in Down Syndrome B-cell Leukemia.

Laurent A, Siret A, Ignacimouttou C, Panchal K, Diop M, Jenni S Clin Cancer Res. 2020; 26(13):3307-3318.

PMID: 32220889 PMC: 7334063. DOI: 10.1158/1078-0432.CCR-19-3519.


Single-chromosome Gains Commonly Function as Tumor Suppressors.

Sheltzer J, Ko J, Replogle J, Habibe Burgos N, Chung E, Meehl C Cancer Cell. 2017; 31(2):240-255.

PMID: 28089890 PMC: 5713901. DOI: 10.1016/j.ccell.2016.12.004.


Evaluation of ETV6/RUNX1 Fusion and Additional Abnormalities Involving ETV6 and/or RUNX1 Genes Using FISH Technique in Patients with Childhood Acute Lymphoblastic Leukemia.

Aydin C, Cetin Z, Manguoglu A, Tayfun F, Altiok Clark O, Kupesiz A Indian J Hematol Blood Transfus. 2016; 32(2):154-61.

PMID: 27065576 PMC: 4789003. DOI: 10.1007/s12288-015-0557-7.


Increased μ-Calpain Activity in Blasts of Common B-Precursor Childhood Acute Lymphoblastic Leukemia Correlates with Their Lower Susceptibility to Apoptosis.

Mikosik A, Henc I, Ruckemann-Dziurdzinska K, Frackowiak J, Ploszynska A, Balcerska A PLoS One. 2015; 10(8):e0136615.

PMID: 26317226 PMC: 4552652. DOI: 10.1371/journal.pone.0136615.